Christopher Gagliardi
Directeur/Membre du Conseil chez I2o Therapeutics, Inc.
Profil
Christopher Gagliardi has held multiple current jobs.
He is currently the Director at I2o Therapeutics, Inc. Additionally, he holds the position of Principal at Sanofi Ventures since 2017.
He is also a Board member at Minervax ApS since 2020.
In terms of education, Dr. Gagliardi completed his undergraduate degree at Roger Williams University and obtained a doctorate degree from The University of North Carolina at Chapel Hill.
Postes actifs de Christopher Gagliardi
| Sociétés | Poste | Début |
|---|---|---|
I2o Therapeutics, Inc.
 I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Directeur/Membre du Conseil | - |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/11/2017 |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | 01/12/2020 |
Formation de Christopher Gagliardi
| Roger Williams University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
I2o Therapeutics, Inc.
I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Health Technology |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Minervax ApS
Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |